{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:35:04Z","timestamp":1761510904188},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s11910-005-0026-z","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T10:17:13Z","timestamp":1180088233000},"page":"66-71","source":"Crossref","is-referenced-by-count":6,"title":["Inflammatory neuropathies"],"prefix":"10.1007","volume":"5","author":[{"given":"Hannah R.","family":"Briemberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony A.","family":"Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"26_CR1","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"BC Jacobs","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, van der Meche N, et al.: The spectrum of antecedent infections in Guillain Barre syndrome. A casecontrol study. Neurology 1998, 51:1110\u20131115.","journal-title":"Neurology"},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","volume":"48","author":"K Ogawara","year":"2000","unstructured":"Ogawara K, Kuwabara S, Mori, et al.: Axonal Guillain-Barre syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000, 48:624\u2013631.","journal-title":"Ann Neurol"},{"issue":"1-2","key":"26_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-510X(02)00418-5","volume":"208","author":"TH Brannagan 3rd","year":"2003","unstructured":"Brannagan TH 3rd, Zhou Y: HIV-associated Guillain-Barre syndrome. J Neurol Sci 2003, 208(1-2):39\u201342.","journal-title":"J Neurol Sci"},{"key":"26_CR4","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.49.6.1711","volume":"49","author":"PY Wen","year":"1997","unstructured":"Wen PY, Alyea EP, Simon D, et al.: Guillain-Barre syndrome following allogeneic bone marrow transplantation. Neurology 1997, 49:1711\u20131714.","journal-title":"Neurology"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","volume":"339","author":"T Lasky","year":"1998","unstructured":"Lasky T, Terracciano GJ, Magder L, et al.: The Guillain-Barre syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines. N Engl J Med 1998, 339:1797\u20131802.","journal-title":"N Engl J Med"},{"key":"26_CR6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jnnp.73.3.348","volume":"73","author":"J Pritchard","year":"2002","unstructured":"Pritchard J, Mukherjee R, Hughes RA: Risk of relapse of Guillain-Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunization. J Neurol Neurosurg Psychiatry 2002, 73:348\u2013349.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"26_CR7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/WNL.55.3.452","volume":"55","author":"EF Wijdicks","year":"2000","unstructured":"Wijdicks EF, Fletcher DD, Lawn ND: Influenza vaccine and the risk of relapse of Guillain-Barre syndrome. Neurology 2000, 55:452\u2013453.","journal-title":"Neurology"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/01.WNL.0000096166.28131.4C","volume":"61","author":"SJ Oh","year":"2003","unstructured":"Oh SJ, Kurokawa K, de Almeida DF, Ryan HF Jr, Claussen GC: Subacute inflammatory demyelinating polyneuropathy. Neurology 2003, 61:1507\u20131512.","journal-title":"Neurology"},{"key":"26_CR9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.64.1.74","volume":"64","author":"JH Rees","year":"1998","unstructured":"Rees JH, Thompson RD, Smeeton NC, Hughes RA: Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry 1998, 64:74\u201377.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"26_CR10","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1212\/WNL.54.12.2311","volume":"54","author":"DD Fletcher","year":"2000","unstructured":"Fletcher DD, Lawn ND, Wolter TD, Wijdicks EF: Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation. Neurology 2000, 54:2311\u20132315.","journal-title":"Neurology"},{"key":"26_CR11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1212\/01.WNL.0000081231.08914.A1","volume":"61","author":"A Hiraga","year":"2003","unstructured":"Hiraga A, Mori M, Ogawara K, et al.: Differences in patterns of progression in demyelinating and axonal Guillain-Barre syndromes. Neurology 2003, 61:471\u2013474.","journal-title":"Neurology"},{"key":"26_CR12","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/WNL.51.6.1656","volume":"51","author":"S Kuwabara","year":"1998","unstructured":"Kuwabara S, Asahina M, Mori M, et al.: Two patterns of clinical recovery in Guillain-Barre syndrome with anti-GM1 antibody. Neurology 1998, 51:1656\u20131660.","journal-title":"Neurology"},{"key":"26_CR13","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1084\/jem.178.5.1771","volume":"178","author":"N Yuki","year":"1993","unstructured":"Yuki N, Taki T, Inagaki F, et al.: A bacterium lipopolysaccaride that elicits Guillain-Barre syndrome has a GM1 gangliosidelike structure. J Exp Med 1993, 178:1771\u20131775.","journal-title":"J Exp Med"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko CE, Sheikh KA, Li CY, et al.: Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996, 39:625\u2013635.","journal-title":"Ann Neurol"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko CE, Hsieh ST, Li CY, et al.: Acute motor axonal neuropathy: an antibody mediated attack on axolemma. Ann Neurol 1996, 40:635\u2013644.","journal-title":"Ann Neurol"},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","volume":"61","author":"RA Hughes","year":"2003","unstructured":"Hughes RA, Wijdicks EF, Barohn R, et al.: Practice parameter: immunotherapy for Guillain-Barre syndrome. Report of the Quality of Standard Subcommittee of the American Academy of Neurology. Neurology 2003, 61:736\u2013740. This is an excellent review of the published clinical trials of treatment in GBS with evidence-based recommendations for management of GBS patients.","journal-title":"Neurology"},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","volume":"349","author":"Plasma Exchange\/Sandoglobulin Guillain-Barre Syndrome Trial Group","year":"1997","unstructured":"Plasma Exchange\/Sandoglobulin Guillain-Barre Syndrome Trial Group: Randomised trial of plasma exchange, intravenous immunoglobulin and combined treatments in Guillain-Barre syndrome. Lancet 1997, 349:225\u2013230.","journal-title":"Lancet"},{"key":"26_CR18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","volume":"363","author":"R Koningsveld van","year":"2004","unstructured":"van Koningsveld R, Schmitz PI, van der Meche FG, et al.: Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomized trial. Lancet 2004, 363:192\u2013196.","journal-title":"Lancet"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","volume":"41","author":"Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","year":"1991","unstructured":"Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force: Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Adacemy of Neurology AIDS Task Force. Neurology 1991, 41:617\u2013618.","journal-title":"Neurology"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","volume":"46","author":"RJ Barohn","year":"1989","unstructured":"Barohn RJ, Kissel JT, Warmolts JR, Mendell JR: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course and recommendations for diagnostic criteria. Arch Neurol 1989, 46:878\u2013884.","journal-title":"Arch Neurol"},{"key":"26_CR21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","volume":"19","author":"B Schimdt","year":"1996","unstructured":"Schimdt B, Toyka KV, Kiefer R, et al.: Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 1996, 19:474\u2013487.","journal-title":"Muscle Nerve"},{"issue":"Suppl 6","key":"26_CR22","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1212\/WNL.59.12_suppl_6.S7","volume":"59","author":"BC Kieseier","year":"2002","unstructured":"Kieseier BC, Dalakas MC, Hartung HP: Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology 2002, 59(Suppl 6):S7-S12.","journal-title":"Neurology"},{"key":"26_CR23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410110205","volume":"11","author":"PJ Dyck","year":"1982","unstructured":"Dyck PJ, O\u2019Brien PC, Oviatt KF, et al.: Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982, 11:136\u2013141.","journal-title":"Ann Neurol"},{"key":"26_CR24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","volume":"314","author":"PJ Dyck","year":"1986","unstructured":"Dyck PJ, Daube J, O\u2019Brien P, et al.: Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986, 314:461\u2013465.","journal-title":"N Engl J Med"},{"key":"26_CR25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","volume":"119","author":"AF Hahn","year":"1996","unstructured":"Hahn AF, Bolton CF, Pillay N, et al.: Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: a double-blind, sham-controlled, cross-over study. Brain 1996, 119:1055\u20131066.","journal-title":"Brain"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/119.4.1067","volume":"119","author":"AF Hahn","year":"1996","unstructured":"Hahn AF, Bolton CF, Zochodne D, Feasby TE: Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebocontrolled, cross-over study. Brain 1996, 119:1067\u20131077.","journal-title":"Brain"},{"key":"26_CR27","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","volume":"36","author":"PJ Dyck","year":"1994","unstructured":"Dyck PJ, Litchy WJ, Kratz KM, et al.: A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994, 36:838\u2013845.","journal-title":"Ann Neurol"},{"key":"26_CR28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.56.4.445","volume":"56","author":"JR Mendell","year":"2001","unstructured":"Mendell JR, Barohn RJ, Freimer ML, et al.: Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001, 56:445\u2013449. This is a randomized controlled trial that demonstrated the efficacy of IVIg as first-line treatment in CIDP.","journal-title":"Neurology"},{"key":"26_CR29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","volume":"50","author":"R Hughes","year":"2001","unstructured":"Hughes R, Bensa S, Wilson H, et al.: Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001, 50:195\u2013201.","journal-title":"Ann Neurol"},{"key":"26_CR30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00415-003-1128-7","volume":"250","author":"AJ Radziwill","year":"2003","unstructured":"Radziwill AJ, Steck AJ, Renaud S, Fuhr P: Distal motor latency and residual latency as sensitive markers of anti-MAG polyneuropathy. J Neurol 2003, 250:962\u2013966.","journal-title":"J Neurol"},{"key":"26_CR31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","volume":"54","author":"JS Katz","year":"2000","unstructured":"Katz JS, Saperstein DS, Gronseth G, et al.: Distal acquired demyelinating symmetric neuropathy. Neurology 2000, 54:615\u2013620. This is a retrospective review article that characterizes a distal variant of CIDP and describes its response to treatment.","journal-title":"Neurology"},{"key":"26_CR32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","volume":"24","author":"DS Saperstein","year":"2001","unstructured":"Saperstein DS, Katz JS, Amato AA, Barohn RJ: Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001, 24:311\u2013324.","journal-title":"Muscle Nerve"},{"key":"26_CR33","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mus.1069","volume":"24","author":"KC Gorson","year":"2001","unstructured":"Gorson KC, Ropper AH, Weinberg DH, Weinstein R: Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy. Muscle Nerve 2001, 24:778\u2013786.","journal-title":"Muscle Nerve"},{"key":"26_CR34","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ana.410400516","volume":"40","author":"MC Dalakas","year":"1996","unstructured":"Dalakas MC, Quarles RH, Farrer RG, et al.: A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol 1996, 40:792\u2013795.","journal-title":"Ann Neurol"},{"key":"26_CR35","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","volume":"325","author":"PJ Dyck","year":"1991","unstructured":"Dyck PJ, Low PA, Windebank AJ, et al.: Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991, 325:1482\u20131486.","journal-title":"N Engl J Med"},{"key":"26_CR36","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/brain\/123.4.710","volume":"123","author":"E Nobile-Orazio","year":"2000","unstructured":"Nobile-Orazio E, Meucci M, Baldini L, et al.: Long-term prognosis of neuropathy associated with anti-MAG IgM Mproteins and its relationship to immune therapies. Brain 2000, 123:710\u2013717.","journal-title":"Brain"},{"key":"26_CR37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q","volume":"22","author":"DS Saperstein","year":"1999","unstructured":"Saperstein DS, Amato AA, Wolfe GI, et al.: Multifocal acquired demyelinating sensory and motor neuropathy. The Lewis-Sumner syndrome. Muscle Nerve 1999, 22:560\u2013566.","journal-title":"Muscle Nerve"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-005-0026-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-005-0026-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-005-0026-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:24:33Z","timestamp":1559420673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-005-0026-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s11910-005-0026-z","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}